Protalix BioTherapeutics Reports Fourth Quarter and Full Year 2019 Financial and Business Results

Go back to Protalix BioTherapeutics Reports Fourth Quarter and Full Year 2019 Financial and Business Results
PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.18 +0.02 (0.93%)
Previous Close $2.16    52 Week High $1.11 
Open $2.15    52 Week Low $0.41 
Day High $2.23    P/E N/A 
Day Low $2.13    EPS $-0.29 
Volume 215,501       

PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.18 +0.02 (0.93%)
Previous Close $2.16    52 Week High $1.11 
Open $2.15    52 Week Low $0.41 
Day High $2.23    P/E N/A 
Day Low $2.13    EPS $-0.29 
Volume 215,501